Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Fabi

Showing results (121-130 of 265) with videos related to

Pageof 27
Sort By:
Cancer Chemotherapy and Pharmacology|October 23, 2009
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiformeGiulio Metro, Alessandra Fabi, Maria A Mirri, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2005
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patientsAlessandra Fabi, Gianluigi Ferretti, Paola Papaldo, et al.
Minerva Surgery|August 2, 2021
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysisArmando Orlandi, Sabatino D'Archi, Giovanna Garufi, et al.
Frontiers in Oncology|April 10, 2024
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysisRoberta Caputo, Giuseppe Buono, Michela Piezzo, et al.
Future Oncology (London, England)|January 19, 2019
Comorbidities in elderly patients with glioblastoma: a field-practice studyVeronica Villani, Antonio Tanzilli, Stefano M Telera, et al.
JCO Oncology Practice|April 27, 2026
Attitudes, Practices, and Barriers to Spiritual Care for Patients With Cancer: An International SurveyCarla Ida Ripamonti, Junita Henry, Christina M Puchalski, et al.
Oncology and Therapy|May 1, 2025
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment PathwayStefania Gori, Alessandra Fabi, Giuseppe Procopio, et al.
Anticancer Research|May 29, 2008
Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and scheduleGiulio Metro, Alessandra Fabi, Michelangelo Russillo, et al.
Breast Cancer Research : BCR|September 6, 2008
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective studyFlavia Novelli, Michele Milella, Elisa Melucci, et al.
Cancers|November 14, 2019
Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT TrialsValentina Rossi, Paola Berchialla, Diana Giannarelli, et al.
Pageof 27

Showing results (121-130 of 265) with videos related to

Sort By:
Pageof 27
Cancer Chemotherapy and Pharmacology|October 23, 2009
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiformeGiulio Metro, Alessandra Fabi, Maria A Mirri, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2005
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patientsAlessandra Fabi, Gianluigi Ferretti, Paola Papaldo, et al.
Minerva Surgery|August 2, 2021
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysisArmando Orlandi, Sabatino D'Archi, Giovanna Garufi, et al.
Frontiers in Oncology|April 10, 2024
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysisRoberta Caputo, Giuseppe Buono, Michela Piezzo, et al.
Future Oncology (London, England)|January 19, 2019
Comorbidities in elderly patients with glioblastoma: a field-practice studyVeronica Villani, Antonio Tanzilli, Stefano M Telera, et al.
JCO Oncology Practice|April 27, 2026
Attitudes, Practices, and Barriers to Spiritual Care for Patients With Cancer: An International SurveyCarla Ida Ripamonti, Junita Henry, Christina M Puchalski, et al.
Oncology and Therapy|May 1, 2025
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment PathwayStefania Gori, Alessandra Fabi, Giuseppe Procopio, et al.
Anticancer Research|May 29, 2008
Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and scheduleGiulio Metro, Alessandra Fabi, Michelangelo Russillo, et al.
Breast Cancer Research : BCR|September 6, 2008
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective studyFlavia Novelli, Michele Milella, Elisa Melucci, et al.
Cancers|November 14, 2019
Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT TrialsValentina Rossi, Paola Berchialla, Diana Giannarelli, et al.
Pageof 27